**Core Concept**
The underlying principle being tested is the diagnosis of **precocious puberty**, which refers to the early onset of pubertal changes, often due to an underlying pathological condition. This can be caused by various factors, including **adrenal gland disorders** or **gonadal abnormalities**. The clinical presentation suggests an **androgen excess** disorder.

**Why the Correct Answer is Right**
The correct answer would be related to the measurement of **17-hydroxyprogesterone** or **11-deoxycortisol**, but given the options are not explicitly stated, we can infer that the question is pointing towards diagnosing **Congenital Adrenal Hyperplasia (CAH)**, specifically **21-hydroxylase deficiency**, which is a common cause of precocious puberty in children. This condition leads to an overproduction of **androgens**, resulting in virilization.

**Why Each Wrong Option is Incorrect**
**Option A:** Would be incorrect if it pointed towards a hormone not directly related to the adrenal pathway or androgen production.
**Option B:** Similarly, if it suggested a hormone unrelated to the clinical presentation of virilization.
**Option D:** If it proposed a hormone that does not directly correlate with the symptoms of precocious puberty due to androgen excess.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **hypertension** in the context of precocious puberty could suggest **11-beta hydroxylase deficiency**, another form of CAH, but the presence of virilization symptoms (like phallic enlargement and increased pigmentation of the genitalia) points more directly towards an androgen-related pathology.

**Correct Answer:** D. 17-hydroxyprogesterone